構造生物学的手法を用いたNR4およびNR6の創薬標的化

• Project/Area Number: 25K02399
• Research Category: Grant-in-Aid for Scientific Research (B)
• Allocation Type: Multi-year Fund
• Section: 一般
• Review Section: Basic Section 47020:Pharmaceutical analytical chemistry and physicochemistry-related
• Research Institution: The University of Osaka
• Principal Investigator: 吉田 卓也 大阪大学, 大学院薬学研究科, 准教授 (00294116)
• Project Period (FY): 2025-04-01 – 2028-03-31
• Project Status: Adopted (Fiscal Year 2025)
• Budget Amount: ¥18,590,000 (Direct Cost: ¥14,300,000、Indirect Cost: ¥4,290,000); Fiscal Year 2027: ¥5,980,000 (Direct Cost: ¥4,600,000、Indirect Cost: ¥1,380,000); Fiscal Year 2026: ¥6,630,000 (Direct Cost: ¥5,100,000、Indirect Cost: ¥1,530,000); Fiscal Year 2025: ¥5,980,000 (Direct Cost: ¥4,600,000、Indirect Cost: ¥1,380,000)